What's in Coherus Oncology, Inc.'s pipeline?

Coherus Oncology, Inc. has 7 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Coherus Oncology, Inc.'s portfolio?

Top competitors by shared drug class: Amgen, Sanofi, Allakos Inc., Atom Therapeutics Co., Ltd, Arrevus Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/coherus-oncology-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Coherus Oncology, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coherus Oncology, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Pegfilgrastim-Cbqv	Pegfilgrastim-Cbqv	marketed	Granulocyte colony-stimulating factor (G-CSF) analog	G-CSF receptor (GCSFR)	Oncology
CHS-1420	CHS-1420	phase 3	Bispecific antibody	CD47 and CD40	Oncology
CHS-0214	CHS-0214	phase 3	Bispecific T-cell engager (BiTE)	CD3 and tumor-associated antigen (specific target not publicly disclosed)	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amgen · 3 shared drug classes
Sanofi · 2 shared drug classes
Allakos Inc. · 1 shared drug class
Atom Therapeutics Co., Ltd · 1 shared drug class
Arrevus Inc. · 1 shared drug class
AstraZeneca · 1 shared drug class
Allergan · 1 shared drug class
Akeso · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Coherus Oncology, Inc.:

Cite this brief

Drug Landscape (2026). Coherus Oncology, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/coherus-oncology-inc. Accessed 2026-05-18.